cutting edge of a new era in medical device care that is witnessing a merging of device and pharmaceutical therapy. Drug-hybrid technologies provide a revolutionary advantage over standard forms of therapy and Japan Stent has …. November 30th, 2009 NEWNAN, Georgia, December 1 – CeloNova BioSciences, Inc., a provider of specialty surface treatments for medical devices and of specialty implants , today announced that Barry Katzen, MD, FACR, FACC, FSCAI, founder and medical …

Here is the original post:
Frost & Sullivan Recognizes Japan Stent Technology for Its …